HIF-1α Decoy Oligodeoxynucleotides Inhibit HIF-1α Signaling and Breast Cancer Proliferation
Overview
Authors
Affiliations
Although HIF-1α is considered an attractive target for the development of cancer therapies, like other transcriptional factors, it has been regarded as 'undruggable'. The decoy approach is a new class of antigene strategy that can be used to modulate the function of endogenous transcriptional factors. Here, we designed a decoy oligodeoxynucleotide (ODN) and tested its effect on the function of HIF-1α. We found the HIF-1α decoy ODN could efficiently enter into cells. Furthermore, these decoy ODNs can significantly block the expression of VEGFA, a known targeted gene of HIF-1α suggesting that the HIF-1α decoy ODNs can inhibit the function of HIF-1α. More importantly, the HIF-1α decoy ODN induced apoptosis and cell cycle arrest in MDA-MB-231 breast cancer cells. In summary, HIF-1α decoy ODNs can inhibit the function of HIF-1α and induce cancer cell apoptosis. Therefore, HIF-1α decoy ODNs should be further modified to improve their biological activity in vivo.
Cancer stem cells and strategies for targeted drug delivery.
Cao J, Bhatnagar S, Wang J, Qi X, Prabha S, Panyam J Drug Deliv Transl Res. 2020; 11(5):1779-1805.
PMID: 33095384 PMC: 8062588. DOI: 10.1007/s13346-020-00863-9.
Yin J, Yi J, Yang C, Xu B, Lin J, Hu H Evid Based Complement Alternat Med. 2019; 2019:2651037.
PMID: 31320912 PMC: 6610735. DOI: 10.1155/2019/2651037.
Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.
Li S, Wei Q, Li Q, Zhang B, Xiao Q Cancer Biol Ther. 2015; 16(6):866-75.
PMID: 25920936 PMC: 4622682. DOI: 10.1080/15384047.2015.1040958.
Ali Hosseini Rad S, Langroudi L, Kouhkan F, Yazdani L, Koupaee A, Asgharpour S Tumour Biol. 2015; 36(7):4871-81.
PMID: 25835969 DOI: 10.1007/s13277-015-3344-z.